H2 gas has just recently hit the forefront of biomedical research, and is still in its infancy with only around 1000 scientific publications, and perhaps 40-50 human studies since 2007.
In more than 350 of those studies, molecular hydrogen has shown therapeutic benefit for 138 disease models.
The Japanese government recently approved H2 inhalation for treatment of post-cardiac arrest patients as it appears to be more effective than conventional treatments at offering neuroprotection.
Human studies, including Tyler’s own study, show great benefits for sports athletes in fatigue, recovery, performance, etc.